Bloomberg Interview with Kevin Hrusovsky

In this conversation with Anne Mostue, Quanterix Chairman and CEO, Kevin Hrusovsky highlights 2019 successes and plans for the future. Also discussed was how Quanterix is working with pharma and biotechnology players to get drugs approved using Quanterix biomarkers to provide efficacy and safety of drugs. 

 

Full interview can be heard here at the 37:46 mark.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more